GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hnf1a | rn6_v1_chr12_+_47407811_47407811 | 0.84 | 1.4e-85 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_-_19132208 Show fit | 885.57 |
ENSRNOT00000060535
|
afamin |
|
chr14_+_20266891 Show fit | 500.56 |
ENSRNOT00000004174
|
group specific component |
|
chr1_+_213511874 Show fit | 488.37 |
ENSRNOT00000078080
ENSRNOT00000016883 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
chr20_-_5123073 Show fit | 472.26 |
ENSRNOT00000001126
|
apolipoprotein M |
|
chr2_+_182006242 Show fit | 467.11 |
ENSRNOT00000064091
|
fibrinogen alpha chain |
|
chr6_-_127620296 Show fit | 443.67 |
ENSRNOT00000012577
|
serpin family A member 1 |
|
chr10_+_89285855 Show fit | 437.75 |
ENSRNOT00000028033
|
glucose-6-phosphatase, catalytic subunit |
|
chr3_+_159902441 Show fit | 419.40 |
ENSRNOT00000089893
ENSRNOT00000011978 |
hepatocyte nuclear factor 4, alpha |
|
chr18_-_38185812 Show fit | 415.85 |
ENSRNOT00000017969
|
serine peptidase inhibitor, Kazal type 1-like |
|
chr3_-_14229067 Show fit | 410.25 |
ENSRNOT00000025534
ENSRNOT00000092865 |
complement C5 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
33.8 | 1386.1 | GO:0051180 | vitamin transport(GO:0051180) |
84.5 | 845.0 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
168.9 | 844.7 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
169.5 | 678.1 | GO:1902569 | regulation of activation of JAK2 kinase activity(GO:0010534) activation of JAK2 kinase activity(GO:0042977) negative regulation of activation of JAK2 kinase activity(GO:1902569) |
178.7 | 536.0 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
97.7 | 488.4 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
37.0 | 481.2 | GO:0052695 | cellular glucuronidation(GO:0052695) |
157.4 | 472.3 | GO:0034444 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
2.3 | 453.9 | GO:0007596 | blood coagulation(GO:0007596) |
29.9 | 448.9 | GO:0015868 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
21.1 | 2486.2 | GO:0072562 | blood microparticle(GO:0072562) |
1.7 | 2318.4 | GO:0005615 | extracellular space(GO:0005615) |
9.3 | 1271.3 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
105.6 | 844.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
2.0 | 794.2 | GO:0005667 | transcription factor complex(GO:0005667) |
0.6 | 791.6 | GO:0005739 | mitochondrion(GO:0005739) |
0.3 | 666.9 | GO:0005576 | extracellular region(GO:0005576) |
0.1 | 634.3 | GO:0016021 | integral component of membrane(GO:0016021) |
1.3 | 595.8 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
94.5 | 472.3 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.0 | 1508.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
10.1 | 885.6 | GO:0019842 | vitamin binding(GO:0019842) |
6.5 | 870.0 | GO:0030674 | protein binding, bridging(GO:0030674) |
169.0 | 845.0 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
97.1 | 679.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
56.5 | 678.1 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
3.0 | 635.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
178.7 | 536.0 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
83.4 | 500.6 | GO:0005499 | vitamin D binding(GO:0005499) |
30.5 | 488.4 | GO:0010181 | FMN binding(GO:0010181) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
51.6 | 2840.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
4.0 | 916.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
27.2 | 844.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
8.9 | 443.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
9.3 | 381.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
7.0 | 355.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
1.1 | 335.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
2.4 | 207.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
6.8 | 202.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
3.0 | 181.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
98.0 | 1568.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
24.3 | 1095.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
33.0 | 892.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
36.5 | 766.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
37.3 | 745.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
45.8 | 595.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
17.8 | 588.8 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
162.8 | 488.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
25.3 | 481.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
5.0 | 443.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |